How much is spent on illicit drugs?

July 2, 2020 Off By idswater

How much is spent on illicit drugs?

The total amount spent on illicit drugs in the United States ranged from $120 billion to $145 billion each year. Midgette and colleagues found that the amount spent on both illegal and legal cannabis increased 50% between 2006 and 2016, from $32 billion to $52 billion.

How much is the illegal drug trade worth annually?

With a world GDP of US$36 trillion in the same year, the illegal drug trade may be estimated as nearly 1% of total global trade.

How much does the US spend on drug treatment?

The largest amount of federal drug control spending was reported for FY 2019 with some 36.8 billion U.S. dollars….

Characteristic Total spending in million U.S. dollars
2019 (Final) 36,808.3
2020 (Enacted) 35,601.4
2021 (Request) 35,695.9

How much is El Chapo worth?

El Chapo: $3 Billion.

How much money is spent on the drug war?

In 2015, the Drug Policy Alliance, which advocates for an end to the War on Drugs, estimated that the United States spends $51 billion annually on these initiatives, and in 2021, after 50 years of the drug war, others have estimated that the US has spent a cumulative $1 trillion on it.

How much money does the US government spend on rehab?

Of the $373.9 billion spent by federal and state governments, some 95.6 percent was spent to “shovel up the consequences and human wreckage of substance abuse and addiction,” while only 1.9 percent was spent on prevention and treatment, 1.4 percent on taxation and regulation, and less than 1 percent on research and …

What is the number 1 selling drug in America?

Best selling pharmaceuticals of U.S. Market

Rank Drug Trade name
1 adalimumab Humira
2 apixaban Eliquis
3 etanercept Enbrel
4 ustekinumab Stelara

What is the number one selling drug in America?

The Medications

Medication Pharmaceutical Company U.S. Sales
1. Humira (Adalimumab) AbbVie $13.7 billion
2. Eliquis (Apixaban) Bristol-Myers Squibb/Pfizer2 $5.61 billion
3. Revlimid (Lenalidomide) Celgene $6.47 billion
4. Keytruda (Pembrolizumab) Merck $4.15 billion